Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1990 May;58(5):1350–1354. doi: 10.1128/iai.58.5.1350-1354.1990

Antiphagocytic effect of the capsule of Staphylococcus simulans.

Y Ohshima 1, F Schumacher-Perdreau 1, G Peters 1, P G Quie 1, G Pulverer 1
PMCID: PMC258631  PMID: 2323819

Abstract

An encapsulated strain of Staphylococcus simulans was observed to be more resistant to phagocytosis by human granulocytes than was a nonencapsulated strain. Phagocytosis of the encapsulated strain was enhanced by antisera to S. simulans, but opsonic activity of antisera was removed by absorption with S. simulans capsular material. The encapsulated strain of S. simulans was also more invasive than the nonencapsulated S. simulans in vivo. More encapsulated than nonencapsulated S. simulans were found in heart blood when equal numbers of organisms were injected intraperitoneally into mice. Invasion of the bloodstreams of mice by encapsulated S. simulans was prevented by passive immunization (rabbit antiserum). Thus, the capsule of S. simulans inhibited phagocytosis in vitro and contributed to virulence in vivo.

Full text

PDF
1350

Images in this article

1351Image
on p.1351

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anderson J. C., Wilson C. D. Encapsulated, coagulase-negative strain of Staphylococcus simulans. Infect Immun. 1981 Jul;33(1):304–308. doi: 10.1128/iai.33.1.304-308.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Archer G. L. Antimicrobial susceptibility and selection of resistance among Staphylococcus epidermidis isolates recovered from patients with infections of indwelling foreign devices. Antimicrob Agents Chemother. 1978 Sep;14(3):353–359. doi: 10.1128/aac.14.3.353. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bender J. W., Hughes W. T. Fatal Staphylococcus epidermidis sepsis following bone marrow transplantation. Johns Hopkins Med J. 1980 Jan;146(1):13–15. [PubMed] [Google Scholar]
  4. Brown E. J., Hosea S. W., Hammer C. H., Burch C. G., Frank M. M. A quantitative analysis of the interactions of antipneumococcal antibody and complement in experimental pneumococcal bacteremia. J Clin Invest. 1982 Jan;69(1):85–98. doi: 10.1172/JCI110444. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. CALLAGHAN R. P., COHEN S. J., STEWART G. T. Septicaemia due to colonization of Spitz-Holter valves by staphylococci. Five cases treated with methicillin. Br Med J. 1961 Mar 25;1(5229):860–863. doi: 10.1136/bmj.1.5229.860. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Christensen G. D., Simpson W. A., Bisno A. L., Beachey E. H. Adherence of slime-producing strains of Staphylococcus epidermidis to smooth surfaces. Infect Immun. 1982 Jul;37(1):318–326. doi: 10.1128/iai.37.1.318-326.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Christensen G. D., Simpson W. A., Bisno A. L., Beachey E. H. Experimental foreign body infections in mice challenged with slime-producing Staphylococcus epidermidis. Infect Immun. 1983 Apr;40(1):407–410. doi: 10.1128/iai.40.1.407-410.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. FISHER M. W., DEVLIN H. B., ERLANDSON A. L. A NEW STAPHYLOCOCCAL ANTIGEN. ITS PREPARATION AND IMMUNIZING ACTIVITY AGAINST EXPERIMENTAL INFECTIONS. Nature. 1963 Sep 14;199:1074–1075. doi: 10.1038/1991074a0. [DOI] [PubMed] [Google Scholar]
  9. Feld R., Leers W. D., Curtis J. E., Bergsagel D. E. Intravenous catheter infection study: a prospective trial in patients with neoplastic disease. Med Pediatr Oncol. 1975;1(2):175–181. doi: 10.1002/mpo.2950010213. [DOI] [PubMed] [Google Scholar]
  10. Fleer A., Senders R. C., Visser M. R., Bijlmer R. P., Gerards L. J., Kraaijeveld C. A., Verhoef J. Septicemia due to coagulase-negative staphylococci in a neonatal intensive care unit: clinical and bacteriological features and contaminated parenteral fluids as a source of sepsis. Pediatr Infect Dis. 1983 Nov-Dec;2(6):426–431. doi: 10.1097/00006454-198311000-00003. [DOI] [PubMed] [Google Scholar]
  11. Fleer A., Verhoef J. New aspects of staphylococcal infections: emergence of coagulase-negative staphylococci as pathogens. Antonie Van Leeuwenhoek. 1984;50(5-6):729–744. doi: 10.1007/BF02386237. [DOI] [PubMed] [Google Scholar]
  12. Hogt A. H., Dankert J., de Vries J. A., Feijen J. Adhesion of coagulase-negative staphylococci to biomaterials. J Gen Microbiol. 1983 Sep;129(9):2959–2968. doi: 10.1099/00221287-129-9-2959. [DOI] [PubMed] [Google Scholar]
  13. Holt R. The classification of staphylococci from colonized ventriculo-atrial shunts. J Clin Pathol. 1969 Jul;22(4):475–482. doi: 10.1136/jcp.22.4.475. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Hostetter M. K. Serotypic variations among virulent pneumococci in deposition and degradation of covalently bound C3b: implications for phagocytosis and antibody production. J Infect Dis. 1986 Apr;153(4):682–693. doi: 10.1093/infdis/153.4.682. [DOI] [PubMed] [Google Scholar]
  15. Ichiman Y. Applications of fluorescent antibody for detecting capsular substances in Staphylococcus epidermidis. J Appl Bacteriol. 1984 Apr;56(2):311–316. doi: 10.1111/j.1365-2672.1984.tb01352.x. [DOI] [PubMed] [Google Scholar]
  16. Ichiman Y., Yoshida K. The relationship of capsular-type of Staphylococcus epidermidis to virulence and induction of resistance in the mouse. J Appl Bacteriol. 1981 Oct;51(2):229–241. doi: 10.1111/j.1365-2672.1981.tb01237.x. [DOI] [PubMed] [Google Scholar]
  17. Marples R. R., Hone R., Notley C. M., Richardson J. F., Crees-Morris J. A. Ivestigation of coagulase-negative staphylococci from infections in surgical patients. Zentralbl Bakteriol Orig A. 1978 Jul;241(1):140–156. [PubMed] [Google Scholar]
  18. Marrie T. J., Kwan C., Noble M. A., West A., Duffield L. Staphylococcus saprophyticus as a cause of urinary tract infections. J Clin Microbiol. 1982 Sep;16(3):427–431. doi: 10.1128/jcm.16.3.427-431.1982. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Melly M. A., Duke L. J., Liau D. F., Hash J. H. Biological properties of the encapsulated Staphylococcus aureus M. Infect Immun. 1974 Aug;10(2):389–397. doi: 10.1128/iai.10.2.389-397.1974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Ohshima Y., Schumacher-Perdreau F., Peters G., Pulverer G. The role of capsule as a barrier to bacteriophage adsorption in an encapsulated Staphylococcus simulans strain. Med Microbiol Immunol. 1988;177(4):229–233. doi: 10.1007/BF00211222. [DOI] [PubMed] [Google Scholar]
  21. Peters G., Locci R., Pulverer G. Adherence and growth of coagulase-negative staphylococci on surfaces of intravenous catheters. J Infect Dis. 1982 Oct;146(4):479–482. doi: 10.1093/infdis/146.4.479. [DOI] [PubMed] [Google Scholar]
  22. Peters G., Saborowski F., Locci R., Pulverer G. Investigations on staphylococcal infection of transvenous endocardial pacemaker electrodes. Am Heart J. 1984 Aug;108(2):359–365. doi: 10.1016/0002-8703(84)90625-2. [DOI] [PubMed] [Google Scholar]
  23. Peterson P. K., Kim Y., Wilkinson B. J., Schmeling D., Michael A. F., Quie P. G. Dichotomy between opsonization and serum complement activation by encapsulated staphylococci. Infect Immun. 1978 Jun;20(3):770–775. doi: 10.1128/iai.20.3.770-775.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Peterson P. K., Wilkinson B. J., Kim Y., Schmeling D., Douglas S. D., Quie P. G., Verhoef J. The key role of peptidoglycan in the opsonization of Staphylococcus aureus. J Clin Invest. 1978 Mar;61(3):597–609. doi: 10.1172/JCI108971. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Speller D. C., Mitchell R. G. Coagulase-negative staphylococci causing endocarditis after cardiac surgery. J Clin Pathol. 1973 Jul;26(7):517–522. doi: 10.1136/jcp.26.7.517. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Verhoef J., Peterson P. K., Quie P. G. Human polymorphonuclear leucocyte receptors for staphylococcal opsonins. Immunology. 1977 Aug;33(2):231–239. [PMC free article] [PubMed] [Google Scholar]
  27. Wallmark G., Arremark I., Telander B. Staphylococcus saprophyticus: a frequent cause of acute urinary tract infection among female outpatients. J Infect Dis. 1978 Dec;138(6):791–797. doi: 10.1093/infdis/138.6.791. [DOI] [PubMed] [Google Scholar]
  28. Wilkinson B. J., Kim Y., Peterson P. K., Quie P. G., Michael A. F. Activation of complement by cell surface components of Staphylococcus aureus. Infect Immun. 1978 May;20(2):388–392. doi: 10.1128/iai.20.2.388-392.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Wilkinson B. J., Peterson P. K., Quie P. G. Cryptic peptidoglycan and the antiphagocytic effect of the Staphylococcus aureus capsule: model for the antiphagocytic effect of bacterial cell surface polymers. Infect Immun. 1979 Feb;23(2):502–508. doi: 10.1128/iai.23.2.502-508.1979. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Wilson P. D., Jr, Amstutz H. C., Czerniecki A., Salvati E. A., Mendes D. G. Total hip replacement with fixation by acrylic cement. A preliminary study of 100 consecutive McKee-Farrar prosthetic replacements. J Bone Joint Surg Am. 1972 Mar;54(2):207–236. [PubMed] [Google Scholar]
  31. Wilson P. D., Jr, Salvati E. A., Aglietti P., Kutner L. J. The problem of infection in endoprosthetic surgery of the hip joint. Clin Orthop Relat Res. 1973 Oct;(96):213–221. [PubMed] [Google Scholar]
  32. Winkelstein J. A., Abramovitz A. S., Tomasz A. Activation of C3 via the alternative complement pathway results in fixation of C3b to the pneumococcal cell wall. J Immunol. 1980 May;124(5):2502–2506. [PubMed] [Google Scholar]
  33. Yoshida K., Ichiman Y., Ohtomo T. Mouse virulent strain of Staphylococcus epidermidis. Relation of antiphagocytic activity to the protection-inducing antigen. Jpn J Microbiol. 1976 Jun;20(3):209–217. [PubMed] [Google Scholar]
  34. Yoshida K., Minegishi Y. Isolation of an encapsulated strain of Staphylococcus epidermidis. J Appl Bacteriol. 1979 Oct;47(2):299–301. doi: 10.1111/j.1365-2672.1979.tb01758.x. [DOI] [PubMed] [Google Scholar]
  35. van de Rijn I., Kessler R. E. Growth characteristics of group A streptococci in a new chemically defined medium. Infect Immun. 1980 Feb;27(2):444–448. doi: 10.1128/iai.27.2.444-448.1980. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES